IDEAS home Printed from https://ideas.repec.org/a/wly/riskan/v34y2014i8p1435-1447.html
   My bibliography  Save this article

Benchmark Dose Calculation for Ordered Categorical Responses

Author

Listed:
  • Chu‐Chih Chen
  • James J. Chen

Abstract

The use of benchmark dose (BMD) calculations for dichotomous or continuous responses is well established in the risk assessment of cancer and noncancer endpoints. In some cases, responses to exposure are categorized in terms of ordinal severity effects such as none, mild, adverse, and severe. Such responses can be assessed using categorical regression (CATREG) analysis. However, while CATREG has been employed to compare the benchmark approach and the no‐adverse‐effect‐level (NOAEL) approach in determining a reference dose, the utility of CATREG for risk assessment remains unclear. This study proposes a CATREG model to extend the BMD approach to ordered categorical responses by modeling severity levels as censored interval limits of a standard normal distribution. The BMD is calculated as a weighted average of the BMDs obtained at dichotomous cutoffs for each adverse severity level above the critical effect, with the weights being proportional to the reciprocal of the expected loss at the cutoff under the normal probability model. This approach provides a link between the current BMD procedures for dichotomous and continuous data. We estimate the CATREG parameters using a Markov chain Monte Carlo simulation procedure. The proposed method is demonstrated using examples of aldicarb and urethane, each with several categories of severity levels. Simulation studies comparing the BMD and BMDL (lower confidence bound on the BMD) using the proposed method to the correspondent estimates using the existing methods for dichotomous and continuous data are quite compatible; the difference is mainly dependent on the choice of cutoffs for the severity levels.

Suggested Citation

  • Chu‐Chih Chen & James J. Chen, 2014. "Benchmark Dose Calculation for Ordered Categorical Responses," Risk Analysis, John Wiley & Sons, vol. 34(8), pages 1435-1447, August.
  • Handle: RePEc:wly:riskan:v:34:y:2014:i:8:p:1435-1447
    DOI: 10.1111/risa.12167
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/risa.12167
    Download Restriction: no

    File URL: https://libkey.io/10.1111/risa.12167?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Kenny S. Crump, 1995. "Calculation of Benchmark Doses from Continuous Data," Risk Analysis, John Wiley & Sons, vol. 15(1), pages 79-89, February.
    2. A. John Bailer & Robert B. Noble & Matthew W. Wheeler, 2005. "Model Uncertainty and Risk Estimation for Experimental Studies of Quantal Responses," Risk Analysis, John Wiley & Sons, vol. 25(2), pages 291-299, April.
    3. Daniel J. Guth & Raymond J. Carroll & Douglas G. Simpson & Haibo Zhou, 1997. "Categorical Regression Analysis of Acute Exposure to Tetrachloroethylene," Risk Analysis, John Wiley & Sons, vol. 17(3), pages 321-332, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Signe M. Jensen & Felix M. Kluxen & Christian Ritz, 2019. "A Review of Recent Advances in Benchmark Dose Methodology," Risk Analysis, John Wiley & Sons, vol. 39(10), pages 2295-2315, October.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Walter W. Piegorsch, 2010. "Translational benchmark risk analysis," Journal of Risk Research, Taylor & Francis Journals, vol. 13(5), pages 653-667, July.
    2. Walter W. Piegorsch & Hui Xiong & Rabi N. Bhattacharya & Lizhen Lin, 2014. "Benchmark Dose Analysis via Nonparametric Regression Modeling," Risk Analysis, John Wiley & Sons, vol. 34(1), pages 135-151, January.
    3. Signe M. Jensen & Felix M. Kluxen & Christian Ritz, 2019. "A Review of Recent Advances in Benchmark Dose Methodology," Risk Analysis, John Wiley & Sons, vol. 39(10), pages 2295-2315, October.
    4. Walter W. Piegorsch & Susan L. Cutter & Frank Hardisty, 2007. "Benchmark Analysis for Quantifying Urban Vulnerability to Terrorist Incidents," Risk Analysis, John Wiley & Sons, vol. 27(6), pages 1411-1425, December.
    5. Kan Shao & Jeffrey S. Gift, 2014. "Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data," Risk Analysis, John Wiley & Sons, vol. 34(1), pages 101-120, January.
    6. Minge Xie & Douglas G. Simpson & Raymond J. Carroll, 2000. "Random Effects in Censored Ordinal Regression: Latent Structure and Bayesian Approach," Biometrics, The International Biometric Society, vol. 56(2), pages 376-383, June.
    7. Katsuyuki Murata & Esben Budtz‐Jørgensen & Philippe Grandjean, 2002. "Benchmark Dose Calculations for Methylmercury‐Associated Delays on Evoked Potential Latencies in Two Cohorts of Children," Risk Analysis, John Wiley & Sons, vol. 22(3), pages 465-474, June.
    8. Zi-Fan Yu & Paul J. Catalano, 2005. "Quantitative Risk Assessment for Multivariate Continuous Outcomes with Application to Neurotoxicology: The Bivariate Case," Biometrics, The International Biometric Society, vol. 61(3), pages 757-766, September.
    9. Kenny S. Grump & Tord Kjellström & Annette M. Shipp & Abraham Silvers & Alistair Stewart, 1998. "Influence of Prenatal Mercury Exposure Upon Scholastic and Psychologica Test Performance: Benchmark Analysis of a New Zealand Cohort," Risk Analysis, John Wiley & Sons, vol. 18(6), pages 701-713, December.
    10. Maria A. Sans‐Fuentes & Walter W. Piegorsch, 2021. "Benchmark dose risk analysis with mixed‐factor quantal data in environmental risk assessment," Environmetrics, John Wiley & Sons, Ltd., vol. 32(5), August.
    11. Kristi Kuljus & Dietrich Von Rosen & Salomon Sand & Katarina Victorin, 2006. "Comparing Experimental Designs for Benchmark Dose Calculations for Continuous Endpoints," Risk Analysis, John Wiley & Sons, vol. 26(4), pages 1031-1043, August.
    12. Edsel A. Peña & Wensong Wu & Walter Piegorsch & Ronald W. West & LingLing An, 2017. "Model Selection and Estimation with Quantal‐Response Data in Benchmark Risk Assessment," Risk Analysis, John Wiley & Sons, vol. 37(4), pages 716-732, April.
    13. Matthew W. Wheeler & Todd Blessinger & Kan Shao & Bruce C. Allen & Louis Olszyk & J. Allen Davis & Jeffrey S Gift, 2020. "Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose–Response Uncertainty," Risk Analysis, John Wiley & Sons, vol. 40(9), pages 1706-1722, September.
    14. Steven B. Kim & Ralph L. Kodell & Hojin Moon, 2014. "A Diversity Index for Model Space Selection in the Estimation of Benchmark and Infectious Doses via Model Averaging," Risk Analysis, John Wiley & Sons, vol. 34(3), pages 453-464, March.
    15. Walter W. Piegorsch & R. Webster West, 2005. "Benchmark Analysis: Shopping with Proper Confidence," Risk Analysis, John Wiley & Sons, vol. 25(4), pages 913-920, August.
    16. Matthew W. Wheeler & A. John Bailer & Tarah Cole & Robert M. Park & Kan Shao, 2017. "Bayesian Quantile Impairment Threshold Benchmark Dose Estimation for Continuous Endpoints," Risk Analysis, John Wiley & Sons, vol. 37(11), pages 2107-2118, November.
    17. Mirjam Moerbeek & Aldert H. Piersma & Wout Slob, 2004. "A Comparison of Three Methods for Calculating Confidence Intervals for the Benchmark Dose," Risk Analysis, John Wiley & Sons, vol. 24(1), pages 31-40, February.
    18. Matteo Goldoni & Maria Vittoria Vettori & Rossella Alinovi & Andrea Caglieri & Sandra Ceccatelli & Antonio Mutti, 2003. "Models of Neurotoxicity: Extrapolation of Benchmark Doses in Vitro," Risk Analysis, John Wiley & Sons, vol. 23(3), pages 505-514, June.
    19. Hoda Izadi & Jean E. Grundy & Ranjan Bose, 2012. "Evaluation of the Benchmark Dose for Point of Departure Determination for a Variety of Chemical Classes in Applied Regulatory Settings," Risk Analysis, John Wiley & Sons, vol. 32(5), pages 830-835, May.
    20. Keiko Kubo & Kazuhiro Nogawa & Teruhiko Kido & Muneko Nishijo & Hideaki Nakagawa & Yasushi Suwazono, 2017. "Estimation of Benchmark Dose of Lifetime Cadmium Intake for Adverse Renal Effects Using Hybrid Approach in Inhabitants of an Environmentally Exposed River Basin in Japan," Risk Analysis, John Wiley & Sons, vol. 37(1), pages 20-26, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:riskan:v:34:y:2014:i:8:p:1435-1447. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1539-6924 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.